Produktname:4-bromo-3,5-dimethyl-1H-pyrazole
IUPAC Name:4-bromo-3,5-dimethyl-1H-pyrazole
- CAS:3398-16-1
- Molekulare Formel:C5H7BrN2
- Reinheit:95%+
- Katalognummer:CM112771
- Molekulargewicht:175.03
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:3398-16-1
- Molekulare Formel:C5H7BrN2
- Schmelzpunkt:-
- SMILES-Code:CC1=C(Br)C(C)=NN1
- Dichte:
- Katalognummer:CM112771
- Molekulargewicht:175.03
- Siedepunkt:341°C at 760 mmHg
- Mdl-Nr.:MFCD00005242
- Lagerung:Store at 2-8°C.
Category Infos
- Pyrazoles
- Pyrazoles are organic compounds of the general formula C3H3N2H. It is a five-membered heterocycle consisting of three carbon atoms and two adjacent nitrogen atoms. As an H-bond-donating heterocycle, pyrazole has been used as a more lipophilic and metabolically more stable bioisomer of phenol. Pyrazoles have attracted more and more attention due to their broad spectrum of action and strong efficacy.
- Pyrazone
- Custom pyrazone for customers from all over the world are our main business.
Column Infos
- Povorcitinib
- Incyte announced results from a Phase 2 study evaluating the efficacy and safety of povorcitinib, an oral JAK1 inhibitor, in adult patients with prurigo nodularis (PN). These data were presented as a late-breaking oral presentation at the American Academy of Dermatology (AAD) Annual Meeting.
Povorcitinib (INCB54707) is an oral small-molecule JAK1 inhibitor currently in Phase 3 clinical trials for hidradenitis suppurativa (HS) and vitiligo. A Phase 3 trial is being planned for PN.